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ABSTRACT  We treated a two-month-old infant, delivered prematurely at 32 weeks of 
gestational age who contracted measles from his mother. We checked him regularly for ten 
years because of the risk of developing subacute sclerosing panencephalitis (SSPE). As a 
result he has been healthy, but his measles specific IgG antibody titer became negative after 
five years and was subsequently boosted with a vaccination. Thus, we determined the IgG and 
IgM antibodies with an ELISA kit in the participating 11 healthy children, who were diagnosed 
as having measles under one year old at our hospital between 2000 and 2006. Two boys had 
an IgG antibody titer of above the upper detection limit, but no participants were negative. 
The measles RNA was not detected with the loop-mediated isothermal amplification in plasma 
and peripheral blood mononuclear cells in the two patients. There have been some reports of 
an early onset and rapidly progressive SSPE after perinatal measles. We infer that specific 
immunity disappearance after infection at an early age due to immature immunity may be 
associated with activating the measles virus remaining in the brain.
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INTRODUCTION
   Subacute sclerosing panencephalitis (SSPE) is a 
slow, progressive degenerative disease of the central 
nervous system caused by a persistent measles virus 
infection. Most patients with SSPE have a history of 
primary measles infection at an early age, which is 
followed by the onset of the progressive neurological 
disorder in a latent period of 6-8 years1）. Typically, 
the neurologic dysfunction begins with behavioral 
difficulties that progress to myoclonic activity and 
eventually into complete neurologic deterioration1）. 
The pathogenesis of the disease is controversial and 
considered to be either a defective production of the 
matrix protein2,3） or fusion protein4） by infected cells 
and an irregular antigenic modulation by antibodies, 
or a disruption of cytokine synthesis, alteration of 
apoptosis and negative signaling of T cells by the 
viral glycoprotein5）.
   In Japan measles epidemics are decreasing, but 
there were epidemics from 2000 to 2001 and from 
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2007 to 2008. We believe that measles still remains 
endemic in Japan; there were approximately 
11,000 measles patients reported in 2008. A second 
immunization was introduced in 2006 in order to 
eliminate this disease by 2012. The inoculation 
rate among one-year-old children reached 94.3% in 
2008. The reported cases of measles decreased to 
736 (5.8/million population) in 2009. 
CASE REPORT
   A two-month-old boy was referred to our hospital 
because his mother was diagnosed as having 
measles. The patient, who was 2,062g at birth, 
was delivered at 32 weeks of gestational age by an 
urgent Caesarean section because of a hemorrhage 
in the lower placenta. The boy was treated for 
respiratory distress syndrome by bronchial 
administration of surfactant and with a respirator 
for seven days. On the referral day, there were no 
symptoms or signs, but he was administered 2.0 
mL of immunoglobulin intramuscularly to prevent 
the measles. However, the next day, the patient was 
admitted to our hospital because of the appearance 
of reddish exanthema and a reduced milk volume 
intake. A physical examination revealed reddish 
maculopapular exanthema mainly on the trunk, but 
Koplik spots were not observed in the oral cavity. 
His father was also admitted to our hospital because 
of measles. A diagnosis of measles in his parents 
was then confirmed by the IgM antibodies and 
significant increases of IgG antibodies. The patient’s 
white blood cell count (WBC) was 14,500/mm3 with 
2% neutrophil bands, 15% segmented neutrophils, 
2% eosinophils, 1% basophils, 12% monocytes, 
59% lymphocytes and 9% atypical lymphocytes. 
The measles specific IgM antibody was positive. 
After his admission, his exanthema spread from the 
trunk to the rest of the body, but his temperature 
remained below 38.0 C and no remarkable cough 
or rhinorrhea developed. We discussed the risk of 
subacute sclerosing panencephalitis (SSPE) in the 
future with his parents, and then obtained their 
Figure.　Alteration of IgG antibodies against measles
The IgG antibodies titers are expressed as ELISA units. The negative and positive cutoff of the IgG value 
is <2.0 and >4.0, respectively. The administered IgG antibody decreased gradually and thereafter the IgG 
antibody titers increased. However, the IgG antibody titer became negative, and was then boosted with the 
vaccination.
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Table.　Characteristics and results of the participating children diagnosed as having measles under one year old.
N
Age of
infection
（months）
Age at collecting
samples
Measles
speciﬁc
IgM（ELISA）
Measles
speciﬁc
IgG（ELISA）
Measles
vaccination
1 11 7Y11M 0.32 62 non
2 8 7Y7M 0.29 12.3 non
3 7 7Y4M 0.53 49.7 non
4 7 7Y4M 0.62 ＞128 non
5 8 7Y4M 0.51 16.4 1　dose
6 4 7Y3M 0.47 52.7 non
7 11 5Y9M 0.52 13.9 1　dose
8 9 8Y2M 0.34 19.6 non
9 10 8Y3M non 21.7 1　dose
10 10 2Y5M 0.48 ＞128 non
11 5 11M 0.36 55.1 non
informed consent to draw cerebrospinal fluid from 
him for a laboratory examination and to monitor his 
development and antibody titer. On the sixth day 
after admission, his cerebrospinal fluid was taken to 
detect the measles virus by culture and RT-PCR6）. 
Both results were negative. 
   The boy’s IgM antibody titer, which was 15.2 at 
the onset, decreased to 6.3 after four weeks and 
was 1.1 at eight weeks after the onset. The changes 
in the measles specific IgG antibody are shown in 
the Figure. The IgM and IgG antibodies titers are 
expressed as ELISA units. The positive cutoff values 
were >1.2 and >4.0, IgM and IgG, respectively. 
His IgG antibody titers decreased to 24.3 after 
four weeks and was 15.7 at eight weeks after the 
onset, but then increased to 25.0 five months later. 
The IgG antibody titers became negative after four 
years, ten months. Furthermore, the virus RNA was 
not detected in his plasma and PBMC with RT-
PCR. He was immunized with a combined measles 
and rubella vaccine, after which his IgG antibody 
increased to 8.5, positive. The IgM antibody, 
however, remained negative. 
SUBJECTS AND METHODS
   The subjects who were diagnosed as having 
measles in infancy under one year old were enlisted 
for this research conducted at Kawasaki Medical 
School Hospital between 2000 and 2006 based on 
clinical features and/or the existence of a positive 
IgM antibody. The collection and use of human 
materials for the present study were approved by 
the Kawasaki Medical School Ethics Committee on 
Human Subjects. Blood were drawn to determine 
the antibodies after informed consents were obtained 
from their guardians. This was done to detect 
SSPE risk in the subjects. We then measured the 
measles RNA using the loop-mediated isothermal 
amplification (LAMP) method7） in the plasma 
and peripheral blood mononuclear cells (PBMC) 
of the subjects who were thought to be at risk of 
developing SSPE. 
RESULTS
   Eleven children were enlisted from the fifteen 
patients diagnosed as having measles under one 
year old. They were from two to four years of age 
and nine (60%) were male. The measles specific 
IgM and IgG antibodies were measured in the serum 
with the ELISA assay (Denka Seiken Co., Japan) 
according to the manufacturer’s instructions. The 
characteristics and results are shown in the Table. 
Two boys had IgG antibody titers above the upper 
detection limit of 128, but no one had a negative 
titer. We asked their guardians about the possibility 
of exposure to measles patients in hospitals or 
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kindergartens, but they were unaware of any recent 
exposure. The measles virus RNA was not detected 
in plasma and PBMC in the two subjects who had 
the titers above the maximum.
DISCUSSION
   Most patients with SSPE have a history of primary 
measles infection at an early age. Children infected 
with measles under the age of one year carry a risk 
16 times greater than those infected at age five year 
or later8）. A higher incidence (male/female ratio 3:1) 
has also been noted in boys9）. The two-month-old 
male patient was delivered at 32 weeks of gestational 
age and contracted measles from his mother. If 
he was born at full term his infection would have 
been classified as perinatal measles. SSPE is 
followed by the onset of a progressive neurological 
disorder in a latent period of 6-8 years. However, 
there have been some reports of a very early 
onset and rapid, progressive SSPE after a perinatal 
measles infection, that is, the congenital10‒13） or 
neonatal infection14）. These observations suggest 
that immature immunity during the intrauterine 
or neonatal period is associated with the failure to 
inhibit a persistent infection in the brain. However, 
there have been few reports on immunoglogical 
observations of infant hosts. 
   The patient and his parents were confirmed 
as having measles through the specific IgM 
antibody against measles. His mother had no past 
history of infection or vaccination. Although we 
administered gammaglobulin to him, the onset 
of an eruption occurred the next day. We thought 
that the administration of gammaglobulin was too 
late to influence his clinical course. However, his 
measles infection was mild. With the presence of 
the transplacental antibodies against measles, the 
clinical course of measles is thought to be usually 
mild. But, in a situation without these antibodies 
such as congenital measles we thought this 
morbidity would be severe. However, the clinical 
courses of neonate cases found in the literatures have 
been described as being mild10‒14）. Chiba et al.15） 
described that the extremely low morbidity of recent 
congenital measles make it difficult to evaluate the 
efficacy of prophylactic immunoglobulin injections 
to infants with a suspicious congenital measles 
infection. The mild morbidity may be related to 
a low immune response such as cytokines. We 
followed up on the patient regularly for ten years 
and as a result he has been healthy. In this case, 
the IgG antibody titers decreased gradually within 
the first four months, which we administered as 
gammaglobulin. Following this the IgG antibody 
titers increased, which were produced by him 
naturally. The IgG antibody titer became negative 
58 months after the onset and was then boosted with 
a vaccination. 
   Because perinatal measles infection is very rare, 
instead of researching it we decided to investigate 
measles cases in patients under one year old, 
who have a risk factor of SSPE. Among the 
participating 11 healthy children, the IgG antibody 
titers were above the upper detection limit in two 
boys. However, they have had no recent history of 
exposure to friends with measles or been in cities 
with epidemics. Therefore, we suspected some 
possibility of pre-stage SSPE in them and expected 
to find the virus RNA, but it was not detected using 
the LAMP method. There has not been any onset 
of SSPE among them, although a few years have 
already passed. Ragazzi et al.16） reported that the 
virus RNA persisted in PBMC for 157 days after 
birth in congenital measles.
   In conclusion, we inferred that the disappearance 
of specific immunity after infection at an early age 
may be one of the pathogenesis of SSPE. However, 
we could not find any patients without the specific 
IgG antibody or detect the virus RNA in the 11 
children who contracted natural measles under one 
year old. However, we believe that further research 
of the kind in this article will be required to clarify 
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the relation of immature immunity and SSPE.
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